Advanced Wound Care Market Overview

The global advanced wound care market is estimated to be worth US$11.2 billion  in2023 and is expected to reach US$17.7 billion by 2030, growing at a CAGR of 9.4% over that period. Studying industry trends in the market is a new research report. The latest research  includes market buying patterns, pricing analysis, patent analysis, conference and webinar materials, and industry trends. Rising spending on chronic wounds, the prevalence of diseases and disorders that impede wound healing, and advances in technology are  key drivers of market growth.

Advanced Wound Care Market Dynamics

Driver: increasing number of surgical procedures across the globe

More operations are anticipated as surgical therapy becomes more available and cheap on a worldwide basis. Along with the development of chronic conditions and the expansion of surgical treatments, the frequency of associated surgical wounds and infections has grown. This will increase demand for better wound care products and debridement techniques in addition to cutting-edge therapies like NPWT.

Surgical procedures frequently cause tissue damage, extreme bleeding, or wound infections. Utilising cutting-edge wound care solutions, such as antibacterial honey wound dressings, has become a viable alternative to hasten the healing process by reducing wound bacterial colonisation and infection. More people are opting to employ sophisticated wound care treatments both before and after surgical operations as a result of a product's demonstrated advantages and the growing public awareness of their efficacy.

Restraint: High cost of advanced wound care products

The expensive cost of modern wound care products and chronic wound therapies may prevent their widespread use, particularly in low-income regions like Asia and the rest of the world. In these areas, patients and doctors choose affordable sophisticated wound care solutions. The preference for advanced wound care products is anticipated to rise over the next years, nevertheless, as more people become aware of the usefulness and necessity of these goods and as disposable incomes rise in many of these nations.

Opportunity: Growth potential of emerging economies

The markets for improved wound treatment in Asia Pacific and Latin America are less developed and offer greater market potential than those in Europe and North America. As a result, different players are concentrating on boosting their presence in certain areas. Major market participants have considerable development prospects in emerging economies including South Korea, Malaysia, Vietnam, South Korea, Africa, Israel, Saudi Arabia, and the United Arab Emirates. This may be as a result of relatively simple rules and restrictions, improvements in healthcare facilities including hospitals and clinics, an escalating patient population, particularly among the elderly, and rising healthcare costs.

Trend: Focus on expanding the current technologies and launching novel products.

The development of new products with absorbent, moisturizing and antibacterial properties is the result of research and development work to improve wound care products, including dressings. This in turn has led to a shift from simple to sophisticated dressings and an increased demand for products containing pharmacologically active ingredients. Market innovations are driven by the need to improve wound bed tissue condition and provide products that control wound healing.

The dressings segment accounted for the largest share of the advanced wound care market by product type.

The worldwide market is divided into topical agents, grafts and matrices, and dressings, devices, and accessories based on products. In 2023, the dressings sector held the biggest market share for advanced wound care, primarily as a result of growing patient education and an increase in HAI cases. This market is growing as a result of elements such the increasing incidence of venous ulcers, pressure ulcers, and diabetic ulcers.

The surgical and traumatic wounds segment accounted for the largest share of the advanced wound care market, by wound type.

The surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, burns, and other wounds are the wound types into which the worldwide market is divided. Due to a rise in surgical operations done and an increase in the occurrence of SSIs, the surgical and traumatic wounds category will have the greatest share of the advanced wound care market in 2023.

Hospitals, ASCs, and wound care centers accounted for the largest share of the advanced wound care market by end user.

Hospitals, ASCs, and wound care facilities are one sector of the worldwide market, along with home care settings and other end users. The sector of hospitals, ASCs, and wound care facilities held the biggest market share for advanced wound care in 2023. The most significant market factors influencing the growth of this end-user category are the rise in hospital admissions for chronic wounds (such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers) and the incidence of pressure ulcers and infections acquired in hospitals.

North America is the largest region of the advanced wound care market.

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the five primary regions of the worldwide market. The biggest market share is held by North America. The increasing number of acquisitions made by well-known North American firms is contributing in the expansion of the worldwide market in this industry. Demographic trends, increased patient awareness, and high market penetration of advanced wound care products are expected to fuel market expansion.

Pipeline Analysis

The advance wound care product pipeline encompasses a range of cutting-edge technologies and therapies designed to address various aspects of wound healing. These advancements are driven by a growing understanding of the complex biological processes involved in wound repair and an increasing demand for more effective treatments.NPWT is a widely adopted technique that involves applying negative pressure to a wound to promote healing.Cellular therapies involve the use of living cells to stimulate tissue repair and regeneration. Stem cell-based therapies, in particular, have shown promise in promoting wound healing by enhancing the production of growth factors and facilitating the regeneration of damaged tissues. Organogenesis Inc. and Osiris Therapeutics are at the forefront of developing cellular therapies for advanced wound care.

Competitive Landscape

As competition intensifies, companies are striving to differentiate themselves through research and development efforts. The future of advance wound care holds great promise for patients and healthcare providers alike, with the potential to transform the way wounds are managed and healed. Key market participants include Smith & Nephew, Mölnlycke Health Care, Acelity, Organogenesis Inc., and Osiris Therapeutics. These companies are investing heavily in research and development activities to bring innovative products to market and gain a competitive edge.

Market Segmentation

  • Advanced Wound Care Market, By Product:
    • Dressings
      • Foam Dressings
      • Silicone Dressings
      • Non-silicone Dressings
      • Hydrocolloid Dressings
      • Film Dressings
      • Alginate Dressings
      • Hydrogel Dressings
      • Collagen Dressings
      • Hydrofiber Dressings
      • Wound Contact Layers
      • Superabsorbent Dressings
      • Other Advanced Dressings
    • Devices & Accessories
      • NPWT Devices & Accessories
      • Debridement Devices & Accessories
      • Wound Assessment & Monitoring Devices
      • Other Devices & Accessories
    • Grafts & Matrices
    • Topical Agents
  • Advanced Wound Care Market, By Wound Type:
    • Surgical & Traumatic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Burns & Other Wounds
  • Advanced Wound Care Market, By End User:
    • Hospitals, ASCs, and Wound Care Centers
    • Home Care Settings
    • Other End Users
  • Advanced Wound Care Market, By Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.